133 related articles for article (PubMed ID: 34431269)
1. A Retrospective Analysis of Fixed Combination of Empagliflozin and Linagliptin in Addition to the Existing Treatment for its Clinical Effectiveness in Adults with Type 2 Diabetes: A Real-World Clinical Experience.
Gupta A; Malhotra P; Jamwal V; Khalse M
J Assoc Physicians India; 2021 Jul; 69(7):11-12. PubMed ID: 34431269
[TBL] [Abstract][Full Text] [Related]
2. Empagliflozin as add-on to linagliptin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a 52-week, randomized, placebo-controlled trial.
Kawamori R; Haneda M; Suzaki K; Cheng G; Shiki K; Miyamoto Y; Solimando F; Lee C; Lee J; George J
Diabetes Obes Metab; 2018 Sep; 20(9):2200-2209. PubMed ID: 29766636
[TBL] [Abstract][Full Text] [Related]
3. Linagliptin as add-on to empagliflozin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two-part, randomized, placebo-controlled trial.
Kaku K; Haneda M; Tanaka Y; Lee G; Shiki K; Miyamoto Y; Solimando F; Lee J; Lee C; George J
Diabetes Obes Metab; 2019 Jan; 21(1):136-145. PubMed ID: 30091172
[TBL] [Abstract][Full Text] [Related]
4. Comparison of efficacy and safety of empagliflozin vs linagliptin added to premixed insulin in patients with uncontrolled type 2 diabetes: A randomized, open-label study.
Liu SC; Lee CC; Chuang SM; Sun FJ; Zeng YH
Diabetes Metab; 2021 May; 47(3):101184. PubMed ID: 32827752
[TBL] [Abstract][Full Text] [Related]
5. Rationality, Efficacy, Tolerability of Empagliflozin Plus Linagliptin Combination for the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials and Observational Studies.
Chenchula S; Varthya SB; Padmavathi R
Curr Diabetes Rev; 2022; 18(4):e100921196392. PubMed ID: 34514991
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of empagliflozin as add-on to metformin for type 2 diabetes: a systematic review and meta-analysis.
Zhong X; Lai D; Ye Y; Yang X; Yu B; Huang Y
Eur J Clin Pharmacol; 2016 Jun; 72(6):655-63. PubMed ID: 26832915
[TBL] [Abstract][Full Text] [Related]
7. Single-pill Combination of Empagliflozin and Linagliptin in Real World Indian Type 2 Diabetes Patient (GRID).
Kovil R; Saboo B; Shah K; Padhye D; Chudasama D; Raj V; Shaikh N
J Assoc Physicians India; 2020 Oct; 68(10):53-55. PubMed ID: 32978926
[TBL] [Abstract][Full Text] [Related]
8. Safety and Tolerability of Combinations of Empagliflozin and Linagliptin in Patients with Type 2 Diabetes: Pooled Data from Two Randomized Controlled Trials.
DeFronzo RA; Lee C; Kohler S
Adv Ther; 2018 Jul; 35(7):1009-1022. PubMed ID: 29949041
[TBL] [Abstract][Full Text] [Related]
9. Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus.
Triplitt C; Solis-Herrera C; Cersosimo E; Abdul-Ghani M; Defronzo RA
Expert Opin Pharmacother; 2015; 16(18):2819-33. PubMed ID: 26583910
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of empagliflozin for type 2 diabetes mellitus: Meta-analysis of randomized controlled trials.
Zhang YJ; Han SL; Sun XF; Wang SX; Wang HY; Liu X; Chen L; Xia L
Medicine (Baltimore); 2018 Oct; 97(43):e12843. PubMed ID: 30412076
[TBL] [Abstract][Full Text] [Related]
11. Safety and tolerability of empagliflozin and linagliptin combination therapy in patients with type 2 diabetes mellitus: a pooled analysis of data from five randomized, controlled clinical trials.
Watada H; Yamauchi T; Yamamoto F; Taniguchi A; Yarush L; Heilmann C; Yasui A
Expert Opin Drug Saf; 2020 Sep; 19(9):1193-1202. PubMed ID: 32552153
[TBL] [Abstract][Full Text] [Related]
12. Empagliflozin/Linagliptin: Combination therapy in patients with type 2 diabetes.
Tan X; Hu J
Ann Endocrinol (Paris); 2016 Oct; 77(5):557-562. PubMed ID: 27062036
[TBL] [Abstract][Full Text] [Related]
13. Real-World Clinical Effectiveness and Tolerability of Hydroxychloroquine 400 Mg in Uncontrolled Type 2 Diabetes Subjects who are not Willing to Initiate Insulin Therapy (HYQ-Real-World Study).
Gupta A
Curr Diabetes Rev; 2019; 15(6):510-519. PubMed ID: 31713476
[TBL] [Abstract][Full Text] [Related]
14. Combination of empagliflozin and linagliptin improves blood pressure and vascular function in type 2 diabetes.
Jung S; Bosch A; Kannenkeril D; Karg MV; Striepe K; Bramlage P; Ott C; Schmieder RE
Eur Heart J Cardiovasc Pharmacother; 2020 Nov; 6(6):364-371. PubMed ID: 31816038
[TBL] [Abstract][Full Text] [Related]
15. Effects on α- and β-cell function of sequentially adding empagliflozin and linagliptin to therapy in people with type 2 diabetes previously receiving metformin: An exploratory mechanistic study.
Forst T; Falk A; Andersen G; Fischer A; Weber MM; Voswinkel S; Heise T; Kapitza C; Plum-Mörschel L
Diabetes Obes Metab; 2017 Apr; 19(4):489-495. PubMed ID: 28009472
[TBL] [Abstract][Full Text] [Related]
16. Empagliflozin/Linagliptin: A Review in Type 2 Diabetes.
Kim ES; Deeks ED
Drugs; 2015 Sep; 75(13):1547-57. PubMed ID: 26323340
[TBL] [Abstract][Full Text] [Related]
17. Fixed-dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta-analysis.
Katsiki N; Ofori-Asenso R; Ferrannini E; Mazidi M
Diabetes Obes Metab; 2020 Jun; 22(6):1001-1005. PubMed ID: 32020696
[TBL] [Abstract][Full Text] [Related]
18. Single-pill combination therapy for type 2 diabetes mellitus: linagliptin plus empagliflozin.
Aronson R
Curr Med Res Opin; 2015 May; 31(5):901-11. PubMed ID: 25775379
[TBL] [Abstract][Full Text] [Related]
19. Empagliflozin/linagliptin single-pill combination therapy for patients with type 2 diabetes mellitus.
Jain RK
Expert Opin Pharmacother; 2017 Apr; 18(6):545-549. PubMed ID: 28375658
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of empagliflozin-based quadruple therapy compared with insulin glargine-based therapy in patients with inadequately controlled type 2 diabetes: An observational study in clinical practice.
Ku EJ; Lee DH; Jeon HJ; Oh TK
Diabetes Obes Metab; 2019 Jan; 21(1):173-177. PubMed ID: 30039538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
